uric acid has been researched along with Placenta Diseases in 4 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Placenta Diseases: Pathological processes or abnormal functions of the PLACENTA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of our study is to appreciate the clinical usefulness of the dosage serum homocysteine and malondialdehyde, as an oxidative stress marker, in the pregnancies complicated with risk of abortion or preterm birth." | 5.38 | The influence of homocysteine and oxidative stress on pregnancy outcome. ( Antal, L; Bodog, A; Bodog, F; Micle, O; Muresan, M, 2012) |
| "In women with SLE with mild-moderate disease activity, ferritin, oestradiol and uric acid levels at mid-gestation may predict preterm birth." | 3.79 | Predictors of preterm birth in patients with mild systemic lupus erythematosus. ( Clowse, ME; Criscione-Schreiber, LG; James, A; Pisetsky, DS; Wallace, DJ; Weisman, M, 2013) |
| " The aim of our study is to appreciate the clinical usefulness of the dosage serum homocysteine and malondialdehyde, as an oxidative stress marker, in the pregnancies complicated with risk of abortion or preterm birth." | 1.38 | The influence of homocysteine and oxidative stress on pregnancy outcome. ( Antal, L; Bodog, A; Bodog, F; Micle, O; Muresan, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Micle, O | 1 |
| Muresan, M | 1 |
| Antal, L | 1 |
| Bodog, F | 1 |
| Bodog, A | 1 |
| Clowse, ME | 1 |
| Wallace, DJ | 1 |
| Weisman, M | 1 |
| James, A | 1 |
| Criscione-Schreiber, LG | 1 |
| Pisetsky, DS | 1 |
| Sims, EA | 1 |
| Fennefrohn, B | 1 |
1 review available for uric acid and Placenta Diseases
| Article | Year |
|---|---|
Pre-eclampsia and related complications of pregnancy.
Topics: Adult; Aldosterone; Angiotensin II; Blood Coagulation Disorders; Catecholamines; Diagnosis, Differen | 1970 |
3 other studies available for uric acid and Placenta Diseases
| Article | Year |
|---|---|
The influence of homocysteine and oxidative stress on pregnancy outcome.
Topics: Biomarkers; C-Reactive Protein; Ceruloplasmin; Female; Homocysteine; Humans; Hyperhomocysteinemia; M | 2012 |
Predictors of preterm birth in patients with mild systemic lupus erythematosus.
Topics: Adult; Biomarkers; Cohort Studies; Comorbidity; Creatine; Estradiol; Female; Ferritins; Gestational | 2013 |
[Examinations of the amniotic fluid in the last weeks of pregnancy. II. Determination of glucose, uric acid, urea nitrogen, lactate dehydrogenase (LDH) and glutamic-oxaloacetic transaminase (GOT)].
Topics: Albumins; Amniotic Fluid; Apgar Score; Aspartate Aminotransferases; Bilirubin; Calcium; Cholesterol; | 1974 |